
#AAO22: In bid for first FDA nod in geographic atrophy, Apellis claims another first in eye disease field
CHICAGO — Eight weeks before patients and industry find out if the FDA approves the first treatment for geographic atrophy, an advanced form of age-related macular degeneration, the biotech behind the drug is out with […]